Red Cedar Investment Management’s AbbVie ABBV Stock Holding History

Red Cedar Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.88M	Sell	27,046 -164	-0.6%	-$36.4K	0.61%	34
2025 Q4	$6.22M	Hold	27,210	–	–	0.67%	29
2025 Q3	$6.3M	Hold	27,210	–	–	0.74%	26
2025 Q2	$5.05M	Hold	27,210	–	–	0.64%	28
2025 Q1	$5.7M	Hold	27,210	–	–	0.79%	19
2024 Q4	$4.84M	Sell	27,210 -8,717	-24%	-$1.6M	0.61%	23
2024 Q3	$7.09M	Hold	35,927	–	–	0.9%	17
2024 Q2	$6.16M	Hold	35,927	–	–	0.84%	18
2024 Q1	$6.54M	Buy	35,927 +3,035	+9%	+$523K	0.82%	19
2023 Q4	$5.1M	Hold	32,892	–	–	0.73%	22
2023 Q3	$4.9M	Buy	32,892 +308	+0.9%	+$45.2K	0.75%	18
2023 Q2	$4.39M	Hold	32,584	–	–	0.67%	22
2023 Q1	$5.19M	Buy	32,584 +10,517	+48%	+$1.61M	0.8%	16
2022 Q4	$3.57M	Buy	22,067 +1,555	+8%	+$238K	0.56%	24
2022 Q3	$2.75M	Buy	20,512 +2,186	+12%	+$314K	0.47%	27
2022 Q2	$2.81M	Sell	18,326 -4,114	-18%	-$629K	0.46%	27
2022 Q1	$3.64M	Buy	22,440 +2,955	+15%	+$429K	0.51%	26
2021 Q4	$2.64M	Hold	19,485	–	–	0.32%	35
2021 Q3	$2.1M	Buy	19,485 +3,273	+20%	+$374K	0.27%	31
2021 Q2	$1.83M	Sell	16,212 -3,273	-17%	-$369K	0.24%	37
2021 Q1	$2.11M	Hold	19,485	–	–	0.27%	34
2020 Q4	$2.09M	Buy	19,485 +16,399	+531%	+$1.58M	0.31%	31
2020 Q3	$270K	Buy	+3,086	New	+$291K	0.05%	71

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Red Cedar Investment Management's ABBV Position: Q1 2026 in Review

Red Cedar Investment Management reduced its AbbVie (ABBV) stake by 0.6% in Q1 2026, selling an estimated $36.4K and leaving 27,046 shares worth $5.88M. The position accounts for 0.61% of the portfolio, ranked #34.

Red Cedar Investment Management first reported a position in ABBV in Q3 2020 and has held it in 23 quarters since. The position peaked at $7.09M in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Red Cedar Investment Management held 27,046 shares of AbbVie worth $5.88M as of Q1 2026.
Red Cedar Investment Management sold 164 AbbVie shares in Q1 2026, an estimated $36.4K.
AbbVie made up 0.61% of Red Cedar Investment Management's portfolio in Q1 2026, its #34 holding.
Red Cedar Investment Management first reported a position in AbbVie in Q3 2020 and has held it in 23 quarters since.
Red Cedar Investment Management's AbbVie position peaked at $7.09M in Q3 2024.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Red Cedar Investment Management's 13F filing for Q1 2026, filed 30 Apr 2026.